Cantor Fitzgerald Reiterates Overweight on PDS Biotechnology

Benzinga · 05/09 15:12
Cantor Fitzgerald analyst Louise Chen reiterates PDS Biotechnology (NASDAQ:PDSB) with a Overweight.